News | News By Subject | News by Disease News By Date | Search News

Diabetes, Type 2 (non-insulin dependent) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Novo Nordisk A/S (NVO)’s Diabetes Drug Beats Out Eli Lilly (LLY)’s Trulicity in Phase III Trials     8/17/2017
Agreement Reached After Novo Nordisk A/S (NVO) is Accused of Disguising Salespeople and Dealing Kickbacks     5/2/2017
This Bay Area Biotech is Being Wooed by Drug Giant Novo Nordisk A/S (NVO)     3/10/2017
Pfizer (PFE) Quietly Kills 3 Pipeline Programs     2/2/2017
Alphabet's Verily, Sanofi (SNY) Launch $500 Million Onduo, Joint Venture to Open New HQ in Kendall Square     9/13/2016
With Hopes of Bolstering Sanofi (SNY)’s Sagging Diabetes Sector, Announces FDA Approval of Adlyxin in U.S.     7/28/2016
FDA Panel Narrowly Backs Cardiovascular Claims for Boehringer Ingelheim, Eli Lilly (LLY)'s Jardiance     6/29/2016
Sanofi (SNY)'s New Diabetes Combo Nails Late-Stage Goals     6/13/2016
Sanofi (SNY) Snags FDA Panel's Support for New Once-Daily Diabetes Combo iGlarLixi     5/26/2016
Oramed (ORMP)'s Oral Insulin Succeeds In Phase IIb Type 2 Diabetes Trial     5/18/2016
Intarcia Touts Large Phase III Trial Diabetes Data, Bags $75 Million     5/6/2016
Eli Lilly (LLY) Abandons Development of Transition Therapeutics (TTH.TO)' Diabetes Candidate TT401     4/19/2016
Sanofi (SNY) Pays $20 Million Milestone and Redeems Priority Review Voucher for Zealand Pharma  (ZEAL.CO)’s LixiLan     12/23/2015
FDA Clears Eli Lilly (LLY)'s Diabetes Drug Basaglar     12/17/2015
Biodel (BIOD) Announces Removal of Partial FDA Clinical Hold on Phase IIb Study 3-250     10/12/2015

News from Around the Web
UK Warns About Alarm Failure for Roche (RHHBY)’s Accu-Check Insight Insulin Pumps     9/21/2017
Love Handles Get Dissolved By New Skin Patch, University of North Carolina Study Reveals     9/18/2017
Tool IDs Diabetes Patients At Risk For Severe Hypoglycemia, Kaiser Permanente Study     8/22/2017
FDA Warns of Leg, Foot Amputations With Johnson & Johnson (JNJ)'s Diabetes Med, Invokana     5/17/2017
New Test IDs Diabetics Who Are At High Risk Of Kidney Failure, Joslin Diabetes Center Study Reveals     4/19/2017
Bay Area's Livongo Rakes in $52.5 Million     3/17/2017
Long Naps Linked To Diabetes, University of Tokyo Study     9/15/2016
Early And Late Menopause Can Increase Risk Of Type 2 Diabetes, Kaiser Permanente Study     7/27/2016
Cycling May Help Lower Type 2 Diabetes Risk, University Of Southern Denmark Study     7/13/2016
Sex Could Play A Role In Type 2 Diabetes Treatment... But Not In The Way You Think, IRCM Study     7/6/2016
Gray Matter Changes In Brains Of Teenagers With Type 2 Diabetes, Cincinnati Children's Hospital Medical Center Scientists Reveal     6/15/2016
GI Windows Anastomosis System For Treating Type 2 Diabetes     6/2/2016
Eating Junk Food Just As Harmful To Kidneys As Diabetes, Anglia Ruskin University Study     5/10/2016
More Blood Vessels In Adipose Tissue May Alleviate Type 2 Diabetes, University of Helsinki Study     4/25/2016
How Depression May Boost Your Type 2 Diabetes Risk, McGill University Study     4/15/2016

Press Releases
Geisinger And Boehringer Ingelheim Collaborate To Create A Predictive Model To Help Improve Health Outcomes For People With Type 2 Diabetes At Greatest Risk Of Serious Long-Term Complications, Including Cardiovascular Death     9/25/2017
Innovation Health Announces Pilot Program With Sanofi (SNY) To Improve Care Delivery For People Living With Type 2 Diabetes     9/25/2017
Novo Nordisk A/S (NVO) Release: Tresiba Trial Shows That People With Type 2 Diabetes Who Avoid Severe Hypoglycemia Have A Reduced Risk Of Death     9/15/2017
Patient-Driven Dose Titration With Sanofi (SNY)'s Toujeo Improved Blood Glucose Control Without Increasing Hypoglycemia Risk In Real-Life Clinical Practice     9/14/2017
Zafgen (ZFGN) Initiates Phase II Clinical Trial For ZGN-1061 In Patients With Type 2 Diabetes     9/13/2017
Novo Nordisk A/S (NVO) Release: Xultophy Reduces Cardiovascular Risk Factors In People With Type 2 Diabetes     9/13/2017
Eli Lilly (LLY) Release: Jardiance (Empagliflozin) Tablets Reduced Risk Of Cardiovascular Death In People With Type 2 Diabetes And Established Cardiovascular Disease Independent Of Background Blood Sugar Control     9/12/2017
Sanofi (SNY)'s Soliqua 100/33 Provided Earlier Blood Sugar Control Than Insulin Glargine 100 Units/mL     9/12/2017
Medtronic (MDT) Recalls Defective Diabetes Infusion Sets     9/11/2017
Caladrius Biosciences (CLBS) Announces Enrollment Of The 70th Subject In The Phase II T-Rex Clinical Trial Of CLBS03 For Type 1 Diabetes     9/5/2017
American Diabetes Association And Good Measures Collaborate To Prevent And Delay Type 2 Diabetes     9/5/2017
Integrity Applications Release: GlucoTrack Presents An Innovation In Type 2 Diabetes Management At The Upcoming EASD In Lisbon, Portugal     9/5/2017
Nemaura Medical Develops Medical Grade SugarBEAT Android App For Diabetes Management     8/30/2017
DexCom (DXCM) Release: New Study Shows People With Type 2 Diabetes Benefit From Continuous Glucose Monitoring     8/22/2017
Boehringer Ingelheim And Eli Lilly (LLY) To Support New American College Of Cardiology Program To Highlight The Increasingly Important Role Of Cardiologists In Reducing Cardiovascular Risk And Cardiovascular Death In People With Type 2 Diabetes     7/31/2017

//-->